US Patent Issued to Fondazione del Piemonte per l'Oncologia on Oct. 28 for "Antisense oligonucleotide sequences for silencing the human L1-MET transcript in tumors" (Italian Inventor)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,454,692, issued on Oct. 28, was assigned to Fondazione del Piemonte per l'Oncologia (Turin, Italy).

"Antisense oligonucleotide sequences for silencing the human L1-MET transcript in tumors" was invented by Tiziana Venesio (Turin, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention concerns the use of antisense oligonucleotides to induce the death of several types of human cancer cells by silencing human L1-MET, which is a non coding transcript specifically transcribed in tumour cells."

The patent was filed on Nov. 13, 2020, under Application No. 17/776,399.

*For further information, including images, charts and tables, please vi...